| 摘要 |
The present invention is concerned with the use of carbonylamino derivatives of the formulawhereinR signifies lower alkyl, lower alkenyl, lower alkinyl, cycloalkyl, lower alkoxy or CF3;R1 signifies hydrogen or lower alkyl;R2 and R3 signify, independently from each other, hydrogen, halogen or nitro;Y signifies CH or N;n is 0-6;m is 0-2;as well as with their pharmaceutically acceptable salts for the treatment of diseases, which relate to metabotropic glutamate receptor antagonists and/or agonists. |
